We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
(-3.5%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$72.5M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$54.4M |
| 3 |
Blackstone
BX
|
+$44M |
| 4 |
Airbnb
ABNB
|
+$37.4M |
| 5 |
Everest Group
EG
|
+$30.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$57.8M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$39.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$23.8M |
| 4 |
iShares Global Infrastructure ETF
IGF
|
+$19.2M |
| 5 |
PDCE
PDC Energy, Inc.
PDCE
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.73% |
| 2 | Healthcare | 12.76% |
| 3 | Financials | 12.67% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Lifestance Health
LFST
$4.14B
| $1.07M | ﹤0.01% |
155,069
+8,905
| +6% | +$72.2K |
|
2152
Navitas Semiconductor
NVTS
$3.63B
| $1.06M | ﹤0.01% |
152,951
+13,315
| +10% | +$118K |
|
|
NPKI
2153
NPK International
NPKI
$1.14B
| $1.06M | ﹤0.01% |
153,710
+605
| +0.4% | +$3.46K |
|
|
DX
2154
Dynex Capital
DX
$3.21B
| $1.06M | ﹤0.01% |
88,913
+1,726
| +2% | +$21.9K |
|
|
NVRO
2155
DELISTED
NEVRO CORP.
NVRO
| $1.06M | ﹤0.01% |
55,076
+237
| +0.4% | +$5.05K |
|
2156
ATN International
ATNI
$492M
| $1.06M | ﹤0.01% |
33,463
-329
| -1% | -$11.7K |
|
2157
Vita Coco
COCO
$3.6B
| $1.06M | ﹤0.01% |
40,547
+1,512
| +4% | +$40.4K |
|
|
VERV
2158
DELISTED
Verve Therapeutics
VERV
| $1.06M | ﹤0.01% |
79,602
+219
| +0.3% | +$3.53K |
|
2159
Perimeter Solutions
PRM
$5.77B
| $1.05M | ﹤0.01% |
232,261
+4,175
| +2% | +$23.3K |
|
2160
Center Bancorp
CNOB
$1.78B
| $1.05M | ﹤0.01% |
58,954
-376
| -0.6% | -$7.05K |
|
|
EB
2161
DELISTED
Eventbrite
EB
| $1.05M | ﹤0.01% |
106,372
+4,060
| +4% | +$41.6K |
|
2162
Yext
YEXT
$574M
| $1.05M | ﹤0.01% |
165,682
-193
| -0.1% | -$1.65K |
|
|
LPRO
2163
DELISTED
Open Lending Corp
LPRO
| $1.05M | ﹤0.01% |
143,202
+3,102
| +2% | +$28.4K |
|
|
EQRX
2164
DELISTED
EQRx, Inc. Common Stock
EQRX
| $1.05M | ﹤0.01% |
472,134
+18,866
| +4% | +$40.4K |
|
2165
Life Time Group Holdings
LTH
$9.79B
| $1.05M | ﹤0.01% |
68,772
+2,030
| +3% | +$35.8K |
|
2166
Argan
AGX
$8.37B
| $1.05M | ﹤0.01% |
22,978
+417
| +2% | +$17.2K |
|
2167
Kinetik
KNTK
$7.98B
| $1.04M | ﹤0.01% |
30,951
+181
| +0.6% | +$6.37K |
|
2168
Opko Health
OPK
$1.02B
| $1.04M | ﹤0.01% |
648,885
+181
| +0% | +$330 |
|
2169
Clearfield
CLFD
$374M
| $1.04M | ﹤0.01% |
36,221
+160
| +0.4% | +$6.28K |
|
2170
Keros Therapeutics
KROS
$221M
| $1.04M | ﹤0.01% |
32,543
-410
| -1% | -$15.3K |
|
2171
Mizuho Financial
MFG
$130B
| $1.03M | ﹤0.01% |
300,910
+6,956
| +2% | +$23.1K |
|
2172
Patria Investments
PAX
$1.86B
| $1.03M | ﹤0.01% |
70,738
+5,225
| +8% | +$77.6K |
|
2173
W&T Offshore
WTI
$518M
| $1.03M | ﹤0.01% |
235,264
+36,590
| +18% | +$151K |
|
2174
ADMA Biologics
ADMA
$2.22B
| $1.03M | ﹤0.01% |
287,730
+8,106
| +3% | +$31.2K |
|
|
DCPH
2175
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.03M | ﹤0.01% |
80,795
+459
| +0.6% | +$6.33K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
- RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
- RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
- RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
- RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.
Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.